EYE - National Vision Holdings Company Value to Earnings Growth Ratio

Brandmark of America's Best Contacts & Eyeglasses (EYE)

The potential of National Vision Holdings (EYE) is based on partnerships with major chains and stable demand for vision diagnostics, which is supported by the P/E growth potential metric. Meanwhile, the 0.81 value reflects current dynamics. Risks are linked to a reduction in consumer spending and pricing pressure from online platforms, although the high efficiency of its own optical laboratories guarantees uninterrupted product output.

EYE (National Vision) PEG Multiple history from 07/04/2022 to 11/16/2026

Analytical breakdowns for National Vision Holdings, Inc. (EYE)

- stock price and consensus target price:
- market capitalization statistics:
Fundamental company analysis:EYE - America's Best Contacts & Eyeglasses
Brand item of National Vision

From a portfolio manager's perspective, this comparison of P/E and growth rates identifies undervalued assets by dividing the current earnings multiple by the expected growth rate. For National Vision Holdings (EYE), this indicator is critical, as it demonstrates how effectively expansion into the US budget optical segment and the development of proprietary brands are converting into equity market value.

Competitors of National Vision Holdings

HCA Holdings - Growth-Adjusted P/E Ratio|Tenet - Price/Earnings to Growth Multiple|Company Value to Earnings Growth Ratio FMS (Fresenius Medical Care)|SOLV: Price/Earnings to Growth Multiple|Price to Earnings Adjusted for Growth Rate Encompass Health Corp|Universal Health Services (UHS) - Price/Earnings to Growth Ratio|DaVita Inc. (DVA) - PEG Multiple|RDNT (RadNet Management) - PEG Multiple|Option Care Health, Inc. - Market Cap to Earnings and Growth Ratio|Price/Earnings to Growth Ratio Surgery Partners (SGRY)|PINC - Price to Earnings Adjusted for Growth Rate|PEG Multiple PGNY (Progyny Inc)|Ardent Health Corp (ARDT) - Price to Earnings Adjusted for Growth Rate|SEM: Price/Earnings to Growth Multiple|ASTH - PEG Multiple|MD: PEG Multiple|Market Cap to Earnings and Growth Ratio USPH (US Physical Therapy)|Price/Earnings to Growth Ratio The Pennant Group, Inc.|ORGO - Price to Net Income Growth Ratio|PEG Multiple NUTX|PEG Multiple Auna (AUNA)|PEG Multiple SBC (sbc-holdings.com)|EOLS: Growth-Adjusted P/E Ratio|Community Health Systems Inc - PEG Multiple|Price to Earnings Adjusted for Growth Rate The Beauty Health Company|MediWound Ltd (MDWD) - Price/Earnings to Growth Ratio|BTMD - Growth-Adjusted Market Cap to Net Income|Price/Earnings to Growth Ratio The Joint|Price/Earnings to Growth Multiple DocGo (DCGO)|P3 Health Partners, Inc. (PIII) - Growth-Adjusted Payback Ratio|PEG Multiple Gain Therapeutics (GANX)|PEG Multiple EUDA (EUDA Health)|Growth-Adjusted Payback Ratio BMGL|CollPlant Ltd - PEG Multiple|Price to Net Income Growth Ratio Cuprina Holdings (Cayman) Ltd. (CUPR)|Concord Medical Corp (CCM) - Price/Earnings to Growth Ratio|ASHS - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio MEDIROM Healthcare Group|PEG Multiple avalon-globocare.com|PEG Multiple DHAI|XAGE (Carmell Therapeutics Corporation) - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio NewGenIvf Corp NIVF|ATIP (atipt.com) - Market Cap to Earnings and Growth Ratio|CareMax, Inc - PEG Multiple|Growth-Adjusted Payback Ratio KDLY (Kindly MD, Inc.)|MODV: PEG Multiple|Growth-Adjusted P/E Ratio NVOS|Price/Earnings to Growth Ratio SunLink Health Systems, Inc.|PEG Multiple IMAC Holdings, Inc.